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Abstract
Tissue Inhibitors of Metalloproteinases (TIMPs) are the natural inhibitors of
Matrix Metalloproteinases (MMPs), a family of proteins primarily responsible for
Extracellular Matrix (ECM) remodeling. TIMP-2 is a special member of the TIMP
family as it is both an inhibitor and promoter of MMP activity, and can also bind the
cell surface and signal inside the cell to influence cell behavior. In this study,
MDAMB-231 and MCF-7 breast cancer cells were treated with physiological
concentrations of TIMP-2, which decreased the invasive potential of both cell lines.
This was independent of MMP inhibition, and instead a decrease in the expression and
secretion of MMP-2 was observed. By using a TIMP-2 mutant, it is likely that the Cterminal domain of unbound TIMP-2 mediated this effect. This study highlights the
pleiotropic functions of TIMP-2 and how inhibition of MMP activity is not a
requirement for the functions of this protein.
Keywords
Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, TIMP-2, MT-1
MMP, MMP-2, breast cancer cells, invasion
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Chapter 1- Introduction
1.1 The Extracellular Matrix
In multicellular organisms cells interact and adhere to one another and to their
surrounding matrix thereby preserving tissue integrity and three-dimensional architecture.
These interactions with the matrix allow the cell to perceive its extracellular milieu and
adapt to environmental changes as cellular functions may require (Gumbiner, 1996;
Nelson and Bissell, 2006). The tissue matrix, or extracellular matrix (ECM), can be
classified into two groups: the stromal matrix and the basement membrane (BM) (Hynes,
2009). The stromal matrix is largely found in connective tissue, such as bone and
cartilage, and is mostly composed of ECM with few imbedded cells. The BM is a
specialized structure that forms a continuous sheet that anchors the epithelium and
endothelium to the connective tissue underneath. The BM acts as mechanical barrier
crucial to the function of cell layers in organs such as the lung and intestine, as well as
having a role in disease progression by preventing malignant cells from invading into
deeper tissues (Bourboulia and Stetler-Stevenson, 2010).
The ECM in connective tissue is normally more abundant than the cells it
surrounds and thus plays a pivotal role in regulating the tissue’s physical properties
(Hynes, 2009). Variations in the relative amount of the different ECM components and
the manner in which they are organized contribute to the various types of tissues present
in animals and allow them to be functionally distinct. The ECM can become calcified to
from hard structures such as bone or teeth, or it can form the transparent matrix of the
cornea, or adopt a ropelike structure that provides tendons their tensile strength.
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The ECM specifically refers to the secreted, interconnected material of assembled
proteins that support and provide environmental cues to cells (Nelson and Bissell, 2006).
The ECM is composed of a variety of fibrous proteins and polysaccharides, such as
fibronectins, laminins and collagens, which are secreted locally and assembled into an
organized meshwork in close association with the surface of the cells that produce them.
The ECM can also be considered a reservoir of biologically active molecules such as
inactive growth factors and other sequestered bioactive molecules, such as fibroblast
growth factors (FGFs) and vascular endothelial growth factors (VEGFs), that can be
released upon matrix degradation and affect cell behaviour (Hynes, 2009). Therefore, the
ECM not only provides a structural barrier to the tissues, organs or cells that it supports,
but also plays an active role in facilitating changes in cellular decisions such as
proliferation, motility and survival (Egeblad and Werb, 2002).
1.2 Matrix Metalloproteinases
Matrix Metalloproteinases (MMPs) belong to a family of secreted zinc-dependent
endopeptidases whose primary function is remodeling of the ECM by selective
proteolytic degradation of ECM components (Kessenbrock et al., 2010). Currently, 24
human MMP members have been identified and divided into five groups according to
their structure and substrate specificity: collagenases, gelatinases, membrane-type,
stromelysins and matrilysins (Bourboulia and Stetler-Stevenson, 2010). However, MMPs
are more commonly classified in two groups based on their cellular localization: secreted
or membrane-anchored.
The MMP family of proteinases is distinguished from other proteinases by the
presence of a conserved HEXXHXXGXX(H/D) histidine sequence motif (where X can

3
be any amino acid) which chelates a zinc atom necessary for catalytic activity (Stocker
and Bode, 1995). All MMPs contain (i) a signal peptide that directs them for secretion or
membrane anchoring, (ii) a propeptide at the N-terminal blocking the catalytic site, and
(iii) a catalytic domain which contains the conserved zinc binding site (Strongin, 2010).
With the exception of MMP-7 and MMP-21, all other MMPs contain a C-terminal
hemopexin-like domain that dictates substrate specificity and mediates interactions with
other proteins. Membrane-type MMPs (MT-1 MMP to MT-4 MMP) are distinguished
from soluble MMPs by an additional single pass transmembrane domain and short
cytoplasmic tail (Sounni et al., 2003). All MMPs are synthesized as inactive proenzymes
that require activation through removal of the pro-peptide blocking the catalytic site (Ra
and Parks, 2007). Membrane-type MMPs are activated intracellularly in the trans-golgi
through a furin dependent mechanism and membrane-anchored in an active form, while
secreted MMPs are secreted as proenzymes that are activated extracellullarly by other
proteases, such as serine proteases or already activated MMPs.
When initially discovered, MMPs were thought to predominantly degrade ECM
components thereby promoting cell migration and affecting cell function by modulating
growth factor availability. However, recent evidence shows that MMPs are also capable
of cleaving chemokines, growth factor receptors, latent growth factors, and cell adhesion
molecules (Egeblad and Werb, 2002). Therefore, MMPs can influence cell behavior by
regulating the integrity and composition of the ECM with which a cell interacts, and also
by regulating the levels of available growth factors and their receptors through cleavage
of ECM and non-ECM pericellular proteins (Fig. 1).
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Figure 1. Matrix Metalloproteinases (MMPs) are proteolytic enzymes that remodel
the ECM as well as directly regulate cell behaviour. Due to the wide variety of
substrates that MMPs can cleave, they can influence cell behaviour by directly regulating
the integrity of the ECM and also by modulating growth factor signaling. Normally, cells
in tissues are attached to the surrounding ECM through integrins, and to neighboring cells
through cell-cell adhesion molecules such as cadherins. Active MMPs can cleave ECM
components (1), as well as cell adhesion proteins (2), liberating the cell from its
attachments to the ECM and to the surrounding cells thereby allowing the cell to migrate.
MMPs are also capable of directly influencing cell behaviour by regulating growth factor
signaling, either by releasing growth factors sequestered in the ECM (3), or cleaving
growth factor receptors at the cell surface (4).
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Due to the overlapping substrate specificities of MMPs, the function of individual
proteases is often determined by their differential expression patterns (Sternlicht and
Werb, 2001). The correct MMPs must be present at the correct time, in the correct
location (extracellular or pericellular) and in the appropriate inhibited or active form. To
achieve a restricted expression profile, MMPs are usually expressed at low levels in
normal tissues, and their cellular localization and activity are tightly controlled at both the
transcriptional and the post-translational levels by cytokines, including interleukins (IL-1,
IL-4 and IL-6), growth factors (epidermal growth factor, hepatocyte growth factor and
transforming growth factor-β), and tumour necrosis factor-α (Sternlicht and Werb, 2001;
Zucker et al., 2003). Additionally, one of the most important ways MMP activity is
controlled is at the level of their enzymatic activity through catalytic inhibition by the
Tissue Inhibitors of Metalloproteinases (TIMPs).
1.3 Tissue Inhibitors of Metalloproteinases
Once activated, MMPs are commonly inhibited by the TIMPs (Lambert et al.,
2004). The mammalian TIMP family consists of four secreted members (TIMP-1, -2, -3,
and -4) that share considerable sequence similarity and structural identity. TIMPs have
two basic structural domains: an N-terminal inhibitory domain that binds non-covalently
to the catalytic site of active MMPs blocking their access to substrates, and a C-terminal
domain that has been shown to bind the hemopexin-like domain of select MMPs
depending on the TIMP (Stetler-Stevenson, 2008a; Tuuttila et al., 1998). All members of
the TIMP family are capable of inhibiting all MMPs, albeit with different efficiencies.
TIMP-1 preferentially inhibits MMP-7, MMP-9, MMP-1 and MMP-3, whereas, TIMP-2
is a more effective inhibitor of MMP-2. TIMP-3 can inhibit MMP-2 and MMP-9,
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whereas, TIMP-4 efficiently inhibits the catalytic activity of MT-1 MMP and MMP-2
(Bourboulia and Stetler-Stevenson, 2010).
TIMPs themselves are regulated at the transcriptional level by various cytokines
and growth factors, resulting in tissue-specific, constitutive, or inducible expression
(Clark et al., 2008). Examples of tissue specific expression include TIMP-1, which is
expressed in reproductive organs, and TIMP-3, which is found in the heart, kidney, and
thymus. TIMP-4 shows the most restricted expression pattern, being predominantly
expressed in the heart and brain (Baker et al., 2002; Nuttall et al., 2004). TIMP-2 is the
only member of the TIMP family that shows constitutive expression. Analysis of the
TIMP-2 promoter reveals several Sp1 sequences characteristic of housekeeping genes,
consistent with the finding that TIMP-2 protein and mRNA shown a constitutive
expression pattern throughout adult murine tissues (Barasch et al., 1999; Blavier and
DeClerck, 1997; Clark et al., 2008).
Similar to MMPs, TIMPs were originally characterized as MMP inhibitors and
thus were thought to function primarily to modulate MMP activity and suppresses ECM
degradation. However, it is now known that TIMPs are multifunctional proteins involved
in several biological activities independent of MMP inhibition, including cell
differentiation, growth, migration, invasion, and apoptosis (Stetler-Stevenson, 2008a).
Therefore, in biological processes such as cell migration, embryogenesis or wound
healing it is very important to have the proper TIMP/MMP balance so as to prevent
excessive MMP proteolysis that is detrimental to cell function while maintaining
sufficiently high levels of free MMPs and TIMPs so that cells continue to behave
normally.
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The importance of having proper TIMP/MMP stoichiometry and the influence
this has on both MMP activity and cell behaviour is best highlighted by the role they play
in cancer and the attempted development of synthetic MMP inhibitors as anti-cancer
therapeutics (Egeblad and Werb, 2002). The expression and activity of all MMPs are
increased in almost every type of human cancer, and this correlates with advanced
tumour stage, increased invasion and metastases, and shortened survival (Curran et al.,
2004; Figueira et al., 2009; Forget et al., 1999; Kohrmann et al., 2009). This is primarily
due to the proteolytic activity of MMPs as they allow cancer cells to invade through the
BM of tissues into blood vessels to then form metastases in other parts of the body (Duffy
et al., 2000). This role of MMPs in invasion, combined with the knowledge that TIMPs
can modulate the invasive activity and metastatic capacity of tumour cells (Albini et al.,
1991; Alvarez et al., 1990; DeClerck et al., 1992; Montgomery et al., 1994), led to the
attempt to generate synthetic MMP inhibitors as a cancer therapy. Although successful in
a number of mouse models (Bramhall et al., 2002; Stetler-Stevenson, 2008a), these
synthetic inhibitors failed to inhibit tumour progression in human clinical trials and often
showed severe toxicities (Coussens et al., 2002; Overall and Lopez-Otin, 2002).
The fact that simple catalytic inhibition by synthetic inhibitors of MMPs failed to
provide the desired results as a cancer treatment clearly highlights the complexity of the
functions that MMP and TIMP interactions have in regulating events in a biological
system. Just as excessive MMP activity is detrimental, as it is in cancer by allowing
invasion of tumour cells, too little MMP activity is also deleterious as shown by the
toxicity exhibited by synthetic MMP inhibitors used as cancer treatments. It is now
widely recognized that MMPs and TIMPs play a dual role in the process of tumour
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progression by affecting both pro- and anti-tumorigenic activities (Stetler-Stevenson,
2008b). Understanding how MMPs and TIMPs affect cell behaviour, either indirectly
through ECM remodeling and modulation of growth factor availability or directly by
binding to cells and regulating cell behaviour, is crucial to forming a comprehensive
understanding of the mechanisms by which these protein families function so one day
these mechanisms may be targeted for the development of therapeutics for diseases such
as cancer.
1.4 TIMP-2
TIMP-2 is the most studied, yet still the most enigmatic member of the TIMP
family of proteins, as it possesses many biological functions that are both dependent and
independent of MMP inhibition (Sounni et al., 2003; Sounni et al., 2010; StetlerStevenson, 2008a; Stetler-Stevenson and Seo, 2005). Like the other TIMPs, TIMP-2 can
bind and inhibit the catalytic activity of MMPs through its N-terminal domain (Fig. 2a).
Counterintuitively, TIMP-2 is also capable of activating proMMP-2, a potent gelatinase
involved in invasion (Itoh et al., 2001). Activating a proMMP is a function unique to
TIMP-2 as no other TIMPs are known to mediate such activation events (Lambert et al.,
2004). In the activation of proMMP-2, MT-1 MMP acts as a cell surface receptor for
TIMP-2 (Fig. 2b). This process involves TIMP-2 binding the hemopexin-like domain of
proMMP-2 with its C-terminal domain and bringing it into close proximity with MT-1
MMP. After formation of the MT-1 MMP/TIMP-2/proMMP-2 complex, MT-1 MMP is
then able to cleave the propeptide of proMMP-2, which then gets released into the
extracellular space as active MMP-2 (Itoh et al., 2001; Lehti et al., 2002). Therefore,
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Figure 2. TIMP-2 is a multifunctional protein that both inhibits and promotes MMP
activity, and can also signal inside the cell to affect cell behaviour. (a) TIMP-2 can
directly inhibit (−|) soluble and membrane-type MMPs by binding their catalytic site
using its N-terminal domain, or (c) indirectly inhibit MMP activity by binding α3β1
integrins with its C-terminal domain and inducing RECK expression. (b) TIMP-2 can
also interact at the cell surface with MT-1 MMP to activate proMMP-2 (pMMP-2) by
facilitating the removal of the propeptide in the catalytic site, while at the same time
signal inside the cell using MT-1 MMP as a receptor. Depending on the MMP/TIMP
stoichiometry, TIMP-2 can positively or negatively regulate cell motility and invasive
potential by modulating MMP activity and cellular signaling cascades.
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TIMP-2 is unique as it is both an inhibitor and promoter of MMP activity, acting in a
contextual manner depending on the relative levels of MT-1 MMP and proMMP-2.
Although TIMP-2-mediated inhibition or promotion of MMP activity is important
in many cellular functions, the idea of MMP-independent TIMP-2 regulation of cell
behaviour has only recently begun to be appreciated. The MMP independent functions of
TIMP-2 are mediated by the C-terminal domain’s ability to bind to cell surface receptors
and cause intracellular signaling cascades (Stetler-Stevenson, 2008a). The first reports of
an MMP-independent function of TIMP-2 came when several laboratories showed that
TIMP-2 promoted cell division, as measured by DNA content or 3H-thymidine uptake, in
various epithelial, mesenchymal, and tumour cell lines (Bertaux et al., 1991; Corcoran
and Stetler-Stevenson, 1995; Hayakawa et al., 1994; Nemeth et al., 1996). This growth
promoting activity of TIMP-2 was demonstrated to be independent of MMP inhibition as
shown through the use of reductive alkylation and mutations at the nucleotide level that
disrupted the ability of TIMP-2 to inhibit MMPs (Chesler et al., 1995; Hayakawa et al.,
1994). Those studies also showed that this function of TIMP-2 is contextual, as growth
promoting activity was only observed in the presence of free TIMPs, and this function
was abolished by complex formation with pro- or active MMPs (Hayakawa et al., 1994).
In addition to reports that describe TIMP-2 growth-promoting activity, there are also
reports that show growth-inhibitory effects of TIMP-2. A study showed that TIMP-2, but
not TIMP-1, inhibits the fibroblast growth factor 2 (FGF-2) stimulated proliferation of
human endothelial cells (Murphy et al., 1993). This suggests that the specific effects of
TIMP-2 on cell behaviour depend on the cell context and the specific model system in
use. These reports led to an increased interest in how TIMP-2 mediates cell behaviour
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independently of MMP inhibition and what its cell surface binding partners may be that
transmit the signal to the inside of the cell.
To investigate what cell surface receptors TIMP-2 binds, a TIMP-2 mutant
protein was created by appending a single alanine to the N-terminal domain, and this
mutant was named ALA+TIMP-2 (Wingfield et al., 1999). The N-terminal alanine
disrupts the ability of TIMP-2 to bind MMPs and thus ALA+TIMP-2 cannot inhibit the
activity of MMP-2 or MT-1 MMP, and is not as efficient at mediating proMMP-2
activation. However, this TIMP-2 mutant protein still possesses a functional C-terminal
domain. Using this protein, it was found that TIMP-2 binding to the cell surface occurs
via the C-terminal domain and is independent of MMP inhibition (Hoegy et al., 2001).
Additionally, it was found that TIMP-2 binding to the cell surface is independent of MT1 MMP levels, and that not all surface-bound TIMP-2 can be released by competitive
binding of synthetic MMP inhibitors (Bernardo and Fridman, 2003; Itoh et al., 1998),
suggesting that other cell surface receptors for TIMP-2 exist apart from MT-1 MMP.
The finding that TIMP-2 binding to the cell surface is partly independent of MT-1
MMP eventually led to the discovery of α3β1 integrins as a cell surface receptor for
TIMP-2 (Seo et al., 2003). Since ALA+TIMP-2 was as efficient at binding to α3β1
integrins as TIMP-2, it suggested that the C-terminal domain mediated this interaction
(Fig. 2c). This was the first demonstration of a TIMP interacting with a specific cell
surface protein that is not a membrane-type MMP. Follow up studies in endothelial cells
demonstrated that TIMP-2 or ALA+TIMP-2 binding α3β1 integrins resulted in cell cycle
arrest and enhanced expression of the cyclin-dependent kinase inhibitor p27Kip1 (Seo et al.,
2006), thus explaining the growth inhibitory effect TIMP-2 has on these cells. Further
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studies also revealed that TIMP-2 and ALA+TIMP-2 binding to α3β1 integrins enhanced
the expression of the reversion-enhancing-cysteine-rich protein with Kazal motifs, also
known as RECK (Oh et al., 2006; Oh et al., 2004). Interestingly, RECK is a relatively
novel membrane-bound MMP inhibitor (inhibits MMP-2, MMP-9 and MT-1 MMP),
which indicates an indirect way that TIMP-2 regulates MMP activity (Rhee and Coussens,
2002). In summary, TIMP-2 is a multifunctional protein that can regulate MMP activity
either directly by binding MMPs or indirectly through upregulation of RECK, and also
affect cell behaviour by binding receptors on the cell surface and signaling inside the cell
(Fig. 2).
1.5 The TIMP-2 paradox in cancer
The expression of MT-1 MMP positively correlates with the malignancy of
different tumour types, such as lung (Nawrocki et al., 1997), gastric (Mori et al., 1997),
and breast carcinomas (Okada et al., 1995), presumably because MT-1 MMP is a potent
proteolytic enzyme that is also involved in proMMP-2 activation, both things which
contribute to tumour progression (Stetler-Stevenson and Yu, 2001). The TIMP-2 paradox
arises from the fact TIMP-2 is a powerful inhibitor of the pro-invasive, pro-tumorigenic
activity of MT-1 MMP, yet at the same time, high levels of TIMP-2 positively correlate
with an unfavorable prognosis in cancer patients (Figueira et al., 2009; Nelson and Bissell,
2006; Strongin, 2010).
Recently it was shown that in addition to regulating ECM remodeling, the MT-1
MMP/TIMP-2 complex also controls cell proliferation and migration through a nonproteolytic mechanism. Using breast cancer cells, two studies have shown that TIMP-2
binds to MT-1 MMP at the cell surface to rapidly induce an intracellular ERK1/2
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signaling cascade, which results in increased migration of breast cancer cells that express
MT-1 MMP at high levels (D'Alessio et al., 2008; Sounni et al., 2010). Importantly, this
induction of the ERK cascade was only observed at physiologically relevant
concentrations of TIMP-2 (10-100 ng/ml) (Murawaki et al., 1999; Pasieka et al., 2004).
Abnormally high, non-physiological concentrations of TIMP-2 (1-5 µg/ml) are often used
in in vitro cell systems (Albini et al., 1991; Hotary et al., 2003; Sabeh et al., 2004), but
these concentrations are 10 to 500 times higher than the concentrations recorded in
tissues and biological fluids. As a result, the functions of TIMP-2 at physiological
relevant concentrations have been largely overlooked. Studying how TIMP-2 functions at
physiological concentrations is essential for a comprehensive understanding of the
diverse mechanisms by which this protein affects cell function.
1.6 Hypothesis and objectives
I hypothesize that physiological concentrations of TIMP-2 modulate invasion
of breast cancer cells through the action of the C-terminal domain and this is
independent of MMP inhibition.
Using MCF-7 and MDAMB-231 breast cancer cell lines, this study was
conducted to examine how physiological concentrations of TIMP-2 affects the invasive
potential of a weakly invasive cell line (MCF-7) in comparison to a highly invasive cell
line (MDAMB-231). To do this, conditioned media containing physiological levels of
TIMP-2 or ALA+TIMP-2 were used to treat MCF-7 and MDAMB-231 cells. These
conditioned media were used to treat breast cancer cells to examine how TIMP-2
influences: 1) invasive potential, 2) MMP activity, 3) secretion of MMP-2, and 4)
changes in RECK, MT-1 MMP, MMP-2, β1 integrin and TIMP-2 transcript levels.
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Chapter 2- Materials and Methods
2.1 Cell culture conditions
Human adenocarcinoma breast cancer cell lines MDAMB-231 and MCF-7 were
generously donated by Dr. Lynne-Marie Postovit, Western University. Cell lines were
cultured in Dulbecco’s Modified Eagles (DMEM)/F-12 medium (Gibco) supplemented
with 10% fetal bovine serum (FBS) and 1% streptomycin/penicillin and incubated at
37°C in a humidified incubator with 5% CO2. Cells were maintained under 80%
confluency and passaged accordingly using 0.25% Trypsin-EDTA (Gibco).
2.2 Transfection
MCF-7 and MDAMB-231 cells were transfected with green fluorescent protein
(GFP), TIMP-2, or ALA+TIMP-2 in the vector pcDNA™ 3.3 TOPO (Invitrogen) using
lipofectamine 2000 (Invitrogen) as per manufacturers’ instructions. One day prior to
transfecting, cells were plated in DMEM/F-12 media with 10% FBS so they were 9095% confluent at the time of transfection. Transfection was done with OPTI-MEM
(Gibco) reduced serum media. To test the transfection efficiency of each cell line, cells
were transfected with GFP and analyzed under a fluorescent microscope after 24 hours.
2.3 Generation of TIMP-2/ALA+TIMP-2 constructs
A vector containing the coding region for human TIMP-2 (Origene, SC118083)
was used to create TIMP-2 and ALA+TIMP-2 constructs in the mammalian constitutive
expression vector pcDNA™ 3.3 TOPO. To PCR amplify the TIMP-2 coding region,
primers complementary to the 5’ and 3’ ends of the coding region were used. To PCR
amplify the ALA+TIMP-2 coding region, the reverse primer used was the same as for
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TIMP-2, but the forward primer was much longer to add an alanine codon after the signal
sequence (Table. 1), such that an alanine exists at the N-terminus of the mature TIMP-2
protein. PCR products for both TIMP-2 and ALA+TIMP-2 were excised from a 1%
agarose gel after gel electrophoresis, purified using the QIAquick® PCR Purification Kit
(QIAGEN®) and individually sub-cloned into pcDNA™ 3.3 TOPO as per manufacturers
instructions. The sub-cloning reactions were transformed into One Shot® Top 10
Chemically Competent E. coli cells (Invitrogen), plated on LB Agar/AMP media and
grown overnight at 37oC. Plasmids from individual colonies were purified using a
QIAprep® Spin Miniprep Kit (QIAGEN®) and sent to the DNA Sequencing Facility at
the Robarts Research Institute (Western University) to confirm the sequence and
orientation of the coding regions within the vector.
2.4 Generation of TIMP-2/ALA+TIMP-2 conditioned media
To investigate how TIMP-2 affects MCF-7 and MDAMB-231 cells, TIMP-2 and
ALA+TIMP-2 conditioned media were created and later used to treat cells. 8x105 MCF-7
cells were plated in 10-cm cell culture dishes (BD Falcon) in DMEM/F-12 media with
10% FBS one day prior to transfection. Cells were transfected with 24 µg of GFP (as a
control, in pcDNATM 3.3 TOPO), TIMP-2 or ALA+TIMP-2 constructs, respectively,
using 60 µl of lipofectamine. After transfection, cells were recovered in DMEM/F-12
media with 10% FBS for 24 hours, and then conditioned media was collected by plating
the cells on serum free DMEM/F-12 media for an additional 24 hours. After collection,
aliquots of GFP, TIMP-2 or ALA+TIMP-2 conditioned media were concentrated using a
Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-10 membrane (Millipore). To
determine that the conditioned media contained elevated levels of TIMP-2/ALA+TIMP-2
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Table 1. TIMP-2 and ALA+TIMP-2 primers
Forward

Reverse

TIMP-2

5’-ATGGGCGCCGCGGCCCGCACC-3’

5’-TTATGGGTCCTCGATGTCGAG-3’

ALA+TIMP-2

5’-ATGGGCGCCGCGGCCCGCACCCTGCGGCTG
GCGCTCGGCCTCCTGCTGCTGGCGACGCTGCTT
CGCCCGGCCGACGCCGCGTGCAGCTGCT-3’

5’-TTATGGGTCCTCGATGTCGAG-3’

Note – Alanine codon is highlighted in the ALA+TIMP-2 forward primer
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protein, a human TIMP-2 enzyme linked immunosorbent assay (ELISA) (R&D Systems)
was used as per manufacturers’ instructions.
2.5 RNA extraction and semiquantitative RT-PCR
To examine how TIMP-2 and ALA+TIMP-2 affect gene expression, mRNA was
extracted from MCF-7 and MDAMB-231 cells after 48 hours of treatment with the
conditioned media. Additionally, gene expression was also compared between MCF-7
and MDAMB-231 cells after being grown for 24 hours on serum-free media. Total RNA
was extracted using the RNAeasy mini kit (Qiagen) according to the manufacturer’s
instructions. 1 µg of RNA was used to synthesize complementary DNA (cDNA) using
qScript™ cDNA SuperMix (Quanta BioSciences). The cDNA was used for semiquantitative RT-PCR to measure transcript levels of RECK, MMP-2, MT-1 MMP, TIMP2, β1 integrin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (as an internal
control) (Table 2). All reactions were performed using the following conditions: 30
cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for 30s. Transcript levels of the
respective genes were quantified by densitometry analysis using QuantityOne® software
and normalized to GAPDH.
2.6 MMP activity assay
To compare the MMP activity in the media between MCF-7 and MDAMB-231
cells, and to examine how treatment for 48 hours with TIMP-2 and ALA+TIMP-2
conditioned media affects the MMP activity of both cell lines, a Mca-K-P-L-G-L-Dpa-AR-NH2 fluorogenic MMP substrate (R&D Systems) was used. When cleaved by MMPs,
the substrate fluoresces and this fluorescence is proportional to the MMP activity in the
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Table 2. RT-PCR primers
Forward

Reverse

RECK

5’- TGCAAGCAGGCATCTTCAAA-3’

5’- ACCGAGCCCATTTCATTTCTG-3’

MMP-2

5’-AGCTCCCGGAAAAGATTGATG-3’

5’- CAGGGTGCTGGCTGAGTAGAT-3’

MT-1 MMP

5’- GCAGAAGTTTTACGGCTTGCA-3’

5’- TCGAACATTGGCCTTGATCTC-3’

TIMP-2

5’- CGACATTTATGGCAACCCTATCA-3’

5’- TCGAACATTGGCCTTGATCTC-3’

β1 integrin

5’- GAACTGCACCAGCCCATTTA-3’

5’- CATCGAAACCACCTTCTGGA-3’

GAPDH

5’- ACCCACTCCTCCACCTTTGA-3’

5’- CTGTTGCTGTAGCCAAATTCGT-3’
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sample. The protein levels in the different TIMP containing or control conditioned media
were quantified using a BCA protein assay kit (Fisher Scientific), and a volume that
corresponds to 15 µg of protein was used for each assay. This volume was diluted in
assay buffer (50 mM Tris, pH 7.5, with 10 mM CaCl, 150 mM NaCl, and 0.05% Brijj-35),
and mixed with the fluorogenic MMP substrate at a final concentration of 10 µM. The
reaction was incubated at 37°C and after 7 hours enzymatic activity was measured using a
fluorescence plate reader.
2.7 Gelatin zymography
Gelatin zymography was performed as previously described (Toth et al., 2012) to
compare the levels of secreted MMP-2 and MMP-9 in the media of MCF-7 and
MDAMB-231 cells, and to examine how levels of secreted MMP-2 change after 48 hours
of treatment with TIMP-2 and ALA+TIMP-2 conditioned media. Briefly, 15 µg of
protein from each medium were loaded on a 10% polyacrylamide-0.1% gelatin gel and
subjected to SDS-PAGE. After electrophoresis, the gels were incubated in renaturing
buffer which renatures MMP species in the gel so they are functional, and then incubated
in developing buffer at 37°C for 48 hours to allow the MMPs to cleave the gelatin in the
gel. After the incubation period, the gel is stained with a 0.5% Coomassie blue, 5%
methanol, 10% acetic acid solution. The gel is then progressively destained with a 20%
methanol, 10% acetic acid solution until bands that represent cleaved gelatin are clearly
visible. Levels of secreted MMP-2 were quantified by densitometry analysis using
QuantityOne® software.
2.8 Invasion assay
An in vitro invasion assay was used to compare the invasive potential of MCF-7
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and MDAMB-231 cells, and to determine how 48 hours of treatment with TIMP-2 or
ALA+TIMP-2 conditioned media affects the invasive potential of both cell lines. The
invasion assays were performed using 24-well, 8 µm pore-size transwell inserts (BD
Biosciences). Stock matrigel (BD Biosciences) was thawed at 4oC and diluted to 1 mg/ml
in serum-free media. 70 µl of the diluted matrigel was pipetted to the center of the
transwell insert, placed in a 24 well plate and then incubated at 37°C for 1 hour to allow
the matrigel to solidify. Fifty thousand cells in 200 µl of the respective conditioned media
were added to the transwell insert on the matrigel, while 500 µl of DMEM medium with
10% FBS was added to the bottom well to act as a chemoattractant that stimulates
invasion. The plates were incubated for 48 hours at 37°C to allow the cells to invade.
Plates were removed after incubation and cells present in the transwell insert were fixed
with 100% methanol. Cells that did not invade through the transwell insert and residual
matrigel were removed from the upper membrane surface with a damp cotton swab.
Invaded cells were then stained with a 0.5% crystal violet solution and residual stain was
removed using a cotton swab. The membranes of the transwell inserts were placed on a
slide and analyzed under a bright field microscope. Invading cells were quantified from
ten 100X field of view images using ImageJ software. This was done by quantifying the
area in pixels that invading cells occupy in the image and then normalizing the data
relative to the highest mean in the sample.
2.9 Statistical analysis
Three biological replicates were done for each experiment. Results were analyzed
using an ANOVA followed by a Tukey’s HSD test. Data are presented as the mean and
standard deviation (SD).
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Chapter 3- Results
3.1 MDAMB-231 cells expressed higher levels of MT-1 MMP, MMP-2, and TIMP-2
than MCF-7 cells
To determine if the expression of RECK, MMP-2, MT-1 MMP and β1 integrin
differs between MDAMB-231 and MCF-7 cells, total RNA was extracted from both cell
lines to quantify the levels of the respective gene transcripts using semi quantitative RTPCR. MMP-2 and MT-1 MMP transcripts could not be detected in MCF-7 cells, whereas
MDAMB-231 cells express both MMP-2 and MT-1 MMP (Fig. 3). As well, MDAMB231 cells express significantly higher levels of TIMP-2 than MCF-7 cells (p ≤ 0.05).
MCF-7 and MDAMB-231 cells did not show a significant difference in the transcript
levels of RECK or β1 integrin.
3.2 MDAMB-231 secreted more MMP-2 and MMP-9, and had higher MMP activity
than MCF-7 cells
To determine if the levels of secreted MMPs and MMP activity differed between
MDAMB-231 and MCF-7 cells, both cell lines were grown in serum-free media, and
after 24 hours the media were collected and assayed for secreted MMP levels and MMP
activity using gelatin zymography and a fluorogenic MMP substrate, respectively (Fig. 4).
After 24 hours, MDAMB-231 cells secreted MMP-2 into the media, as well as some
MMP-9 (Fig. 4a). In contrast, MMP-2 and MMP-9 secreted after 24 hours from MCF-7
cells could not be detected using gelatin zymography. Consistent with the levels of
secreted MMP-2 and MMP-9, MDAMB-231 cells demonstrated significantly higher
MMP activity than MCF-7 cells (p ≤ 0.01) (Fig. 4b).
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Figure 3. MDAMB-231 cells expressed higher levels of MMP-2, MT-1 MMP, and
TIMP-2 than MCF-7 cells. (a) MDAMB-231 and MCF-7 cells were grown in serumfree media for 24 hours, and then mRNA was isolated to examine the expression of β1
integrin, TIMP-2, MT-1 MMP, MMP-2, RECK and GAPDH (as an internal control) using
semi quantitative RT-PCR. (b) Densitometry quantification of transcript levels is shown
as relative expression to GAPDH. MMP-2 and MT-1 MMP transcripts could not be
detected in MCF-7 cells, whereas both transcripts were present in MDAMB-231 cells.
Additionally, MDAMB-231 cells express significantly higher levels of TIMP-2 than
MCF-7 cells. Data are presented as the mean and standard deviation of three independent
experiments. Asterisks denote significant differences at p ≤ 0.05.
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Figure 4. MDAMB-231 cells secreted more MMP-2 and MMP-9, and showed higher
MMP activity than MCF-7 cells. MDAMB-231 and MCF-7 cells were grown in serumfree media for 24 hours, and then the media was used to measure secreted levels of
MMP-2 and MMP-9 using (a) gelatin zymography and (b) MMP activity using a
fluorogenic MMP substrate. (a) MCF-7 cells did not secrete detectable levels of MMP-2
or MMP-9 after 24 hours, while MDAMB-231 cells secreted MMP-2 and MMP-9. (b)
MDAMB-231 cells showed significantly higher MMP activity than MCF-7 cells as
measured by cleavage of a fluorogenic MMP substrate. Data are shown as the mean and
standard deviation of three independent experiments. Asterisks denote a significant
difference at p ≤ 0.01.

27

28
3.4 MDAMB-231 cells displayed higher invasive potential than MCF-7 cells
To compare the invasive potential between MCF-7 and MDAMB-231 cells, both
cell types were allowed to invade through a matrigel-coated transwell insert for 24 hours
(Fig. 5a). MCF-7 cells were 75% less efficient at invading through the matrigel than
MDAMB-231 cells (Fig. 5b). These two cell lines were subsequently treated with TIMP2 and ALA+TIMP-2 conditioned media to compare the effect these conditioned media
have on the invasive efficiency of a cell line with a high invasive potential (MDAMB231), versus a cell line with a low invasive potential (MCF-7).
3.5 MCF-7 cells showed higher transfection efficiency than MDAMB-231 cells
To create TIMP-2 and ALA+TIMP-2 conditioned media, it was important to
determine the transfection efficiency of both cell lines beforehand so that one could be
selected for conditioned media production. MCF-7 cells seemed to be better candidates to
prepare the conditioned media as these cells express MMPs at low levels (Figueira et al.,
2009), and therefore conditioned media made using this cell line would contain low
levels of MMPs that would have otherwise complicated the analysis of data generated via
the conditioned media treatments. MCF-7 cells showed a much higher transfection
efficiency (~80% vs. ~11%, as determined by comparing the phase contrast images to
fluorescent images using ImageJ software) than MDAMB-231 cells as observed by
transfection and expression of GFP (Fig. 6). Hence, MCF-7 cells were subsequently used
to create TIMP-2 and ALA+TIMP-2 conditioned media.
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Figure 5. MDAMB-231 cells displayed higher invasive efficiency than MCF-7 cells.
MDAMB-231 and MCF-7 cells were plated on a matrigel-coated transwell insert and
allowed to invade for 24 hours. (a) Cells that invaded through the matrigel to the bottom
of the transwell were stained with crystal violet and examined using bright field
microscopy at 100x. Scale bars: 100 µm (b) Ten 100x field of view images were
quantified using ImageJ software. MDAMB-231 cells were 75% more efficient at
invading through the matrigel than MCF-7 cells. Data are shown as the mean and
standard deviation of three independent experiments. Asterisks denote a significant
difference at p ≤ 0.01.

30

31
Figure 6. MCF-7 cells showed higher transfection efficiency than MDAMB-231 cells.
MCF-7 and MDAMB-231 cells were transfected with GFP in the vector pcDNA™
TOPO 3.3 using lipofectamine 2000. After 24 hours, transfected cells were examined
under a fluorescent microscope at 100X to visualize GFP expression. Scale bar: 100 µm
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3.6 Transfection of TIMP-2 and ALA+TIMP-2 constructs resulted in production of
conditioned media containing high levels of both proteins
PCR amplification using primers that amplify the full coding region of TIMP-2 or
ALA+TIMP-2 confirmed the expected size amplicons of 663 bp and 666, respectively
(Fig. 7a). These sequences should only differ by a single alanine codon located at the
beginning of the N-terminal sequence of TIMP-2. After ligating the amplicons into the
expression vector pcDNATM TOPO 3.3, both constructs were sequenced and analyzed
using NCBI sequence alignment confirming that both constructs show 100% identity
apart from the alanine codon at the N-terminal of the ALA+TIMP-2 construct (Fig. 7c).
After transfection of these constructs into MCF-7 cells, the media was collected and
assayed for levels of TIMP-2 or ALA+TIMP-2 protein using a human TIMP-2 ELISA.
The TIMP-2/ALA+TIMP-2 conditioned media created using this method contained
significantly higher levels of the respective proteins compared to control media obtained
from GFP transfected cells (Fig. 7b). The determined levels (~42 ng/ml) are well within
physiological levels of TIMP-2 (10-100 ng/ml) (Murawaki et al., 1999; Pasieka et al.,
2004). Additionally, it was important to measure the MMP activity of the conditioned
media prior to cell treatments. Due to TIMP-2/ALA+TIMP-2 overexpression, it was
possible that the MMP activity between the different conditioned media differed thereby
making it difficult to interpret the results after treating cells with these conditioned media.
If MMP activity were to differ between the conditioned media, the effect these media had
in the assays done in this study may not be specific to the increased levels of TIMP2/ALA+TIMP-2, but rather to the difference in MMP activity between the media.
Therefore, the MMP activity of the conditioned media were tested using the fluorogenic
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Figure 7. Transfection of TIMP-2 or ALA+TIMP-2 constructs into MCF-7 cells
resulted in conditioned media containing increased levels of both proteins. (a) PCR
amplification of the coding region of TIMP-2 and ALA+TIMP-2 resulted in two bands of
663 bp and 666 bp, respectively. After ligating these PCR products into the vector
pcDNA™ TOPO 3.3, sequencing the resulting constructs and analyzing the sequence
using NCBI sequence alignment (c), it was found that the ALA+TIMP-2 construct
(Query) showed 100% identity with the TIMP-2 construct (Sbjct), apart from the alanine
codon, GCG (red), after the signal peptide (yellow) at the N-terminus (green) of mature
TIMP-2 protein. (b) After transfecting MCF-7 cells with both constructs, cells were then
plated on serum-free media and after 24 hours this media was collected and the levels of
TIMP-2 or ALA+TIMP-2 protein were measured using a human TIMP-2 ELISA. The
concentration of TIMP-2 in control transfected MCF-7 cells was about 6 ng/ml whereas
the concentration of TIMP-2 or ALA+TIMP-2 in the media of MCF-7 cells transfected
with the respective constructs was approximately 42 ng/ml. Data are presented as the
mean and standard deviation of three independent experiments.
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MMP substrate (Fig. 8). This revealed no significant difference in MMP activity between
TIMP-2 and ALA+TIMP-2 conditioned media and the control media from GFP
transfected cells.
3.7 Both TIMP-2 and ALA+TIMP-2 conditioned media caused a decrease in the
invasive potential of MCF-7 and MDAMB-231 cells
To examine how the TIMP-2 and ALA+TIMP-2 conditioned media affected the
invasive potential MCF-7 and MDAMB-231 cells, cells were incubated in the respective
conditioned media and subsequently allowed to invade through a matrigel-coated
transwell insert for 48 hours. Both TIMP-2 and ALA+TIMP-2 conditioned media caused
a significant decrease in the invasive efficiency of MCF-7 cells as compared to cells
treated with conditioned media from GFP transfected cells (control) (Fig. 9). TIMP-2
conditioned media caused a 33% decrease in the invasive efficiency of MCF-7 cells,
while ALA+TIMP-2 conditioned media caused a 55% decrease in the invasive efficiency
of MCF-7 cells.
Similarly, both TIMP-2 and ALA+TIMP-2 conditioned media caused a decrease in
the invasive efficiency of MDAMB-231 cells (Fig. 10). TIMP-2 conditioned media
caused a 29% decrease in the invasive efficiency of MDAMB-231 cells, while
ALA+TIMP-2 conditioned media caused a 63% decrease in the invasive efficiency of
MDAMB-231 cells.
3.8 TIMP-2 and ALA+TIMP-2 conditioned media caused an increase in the MMP
activity of MCF-7 and MDAMB-231 cells
To examine if the decrease in invasive potential after conditioned media treatment
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Figure 8. The MMP activity of TIMP-2 and ALA+TIMP-2 conditioned media did
not differ from control media. The MMP activity of the conditioned media made in
MCF-7 cells was assayed by measuring the cleavage of a fluorogenic MMP substrate.
The MMP activity in TIMP-2 and ALA+TIMP-2 conditioned media were not
significantly different from each other or control media from GFP transfected cells (p ≤
0.01). Data are presented as the mean and standard deviation of three independent
experiments.
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Figure 9. TIMP-2 and ALA+TIMP-2 conditioned media decreased the invasion
efficiency of MCF-7 cells. MCF-7 cells were plated on top of a matrigel-coated transwell
insert and allowed to invade for 48 hours in the presence of control or TIMP-2 and
ALA+TIMP-2 conditioned media. (a) Cells that invaded through the matrigel to the
bottom of the transwell were stained with crystal violet and examined using bright field
microscopy at 100x. Scale bars: 100 µm (b) Ten 100x field of views were quantified
using ImageJ software and shown as relative invasion compared to MCF-7 cells treated
with control media. Both TIMP-2 and ALA+TIMP-2 conditioned media caused a
significant decrease in the invasion of MCF-7 cells as compared to control. ALA+TIMP2 conditioned media caused the highest significant decrease in the invasion of MCF-7
cells compared to both control and TIMP-2 conditioned media treated cells. Data are
shown as the mean and standard deviation of three independent experiments. Letters
denote significant differences at p ≤ 0.01.
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Figure 10. TIMP-2 and ALA+TIMP-2 conditioned media decreased the invasion
efficiency of MDAMB-231 cells. MDAMB-231 cells were plated on top of a matrigelcoated transwell insert and allowed to invade for 48 hours in the presence of control or
TIMP-2 and ALA+TIMP-2 conditioned media. (a) Cells that invaded through the
matrigel to the bottom of the transwell were stained with crystal violet and examined
using bright field microscopy at 100x. Scale bars: 100 µm (b) Ten 100x field of views
were quantified using ImageJ software and shown as relative invasion compared to
MDAMB-231 cells treated with control media. Both TIMP-2 and ALA+TIMP-2
conditioned media caused a significant decrease in the invasion of MDAMB-231 cells as
compared to control. ALA+TIMP-2 conditioned media caused the highest significant
decrease in the invasion of MDAMB-231 cells compared to both control and TIMP-2
conditioned media treated cells. Data are shown as the mean and standard deviation of
three independent experiments. Letters denote significant differences at p ≤ 0.01.
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was due to a decrease in MMP activity, the fluorogenic MMP substrate was used to
measure MMP activity after 48 hours of treatment with the conditioned media.
Surprisingly, both TIMP-2 and ALA+TIMP-2 conditioned media caused a significant
increase in MMP activity as compared to the control, with ALA+TIMP-2 conditioned
media showing the highest increase in MMP activity in both cell lines. TIMP-2 and
ALA+TIMP-2 conditioned media caused a 39% and 62% increase in MMP activity in
MCF-7 cells, respectively (Fig. 11a). In MDA-MB231 cells, TIMP-2 and ALA+TIMP-2
conditioned media caused a 73% and 149% increase in MMP activity, respectively (Fig.
11b).
3.9 TIMP-2 and ALA+TIMP-2 conditioned media caused a decrease in the amount
of secreted MMP-2 from MDAMB-231 cells
Since the decrease in invasive efficiency was not due to a decrease in MMP activity,
it was then examined if conditioned media treatment affected the levels of secreted
MMP-2. To determine this, cells were incubated in the respective conditioned media for
48 hours then the media was analyzed for secreted MMP-2 levels using gelatin
zymography. In MCF-7 cells, TIMP-2 and ALA+TIMP-2 conditioned media caused a
modest decrease in the levels of secreted MMP-2 (Fig. 12a). However, due to the
difficulty in reliably replicating gelatin zymography (Toth et al., 2012), it cannot be
determined if this decrease is biologically meaningful. In MDAMB-231 cells, both
TIMP-2 and ALA+TIMP-2 conditioned media caused a considerable decrease in the
levels of secreted MMP-2 (Fig. 12b). TIMP-2 conditioned media caused a 16% decrease
in secreted MMP-2, whereas ALA+TIMP-2 conditioned media caused a 50% decrease in
secreted MMP-2.
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Figure 11. Treating MCF-7 and MDAMB-231 cells with TIMP-2 and ALA+TIMP-2
conditioned media caused an increase in MMP activity. After treating cells with
TIMP-2 and ALA+TIMP-2 conditioned media treatment for 48 hours, the MMP activity
in the media was measured using a fluorogenic MMP substrate. Treatment with TIMP-2
and ALA+TIMP-2 conditioned media resulted in a significant increase in MMP activity
in both (a) MCF-7 and (b) MDAMB-231 cells as compared to cells treated with control
media. ALA+TIMP-2 treatment resulted in the highest significant increase in MMP
activity in both cell lines as compared to control and TIMP-2 conditioned media treated
cells. Data are shown as the mean and standard deviation of three independent
experiments. Letters denote significant differences at p ≤ 0.01.
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Figure 12. TIMP-2 and ALA+TIMP-2 conditioned media caused a decrease in the
levels of secreted MMP-2 from MDAMB-231 cells. (a) After treating MCF-7 and
MDAMB-231 cells with TIMP-2 and ALA+TIMP-2 conditioned media for 48 hours, the
media was analyzed using gelatin zymography to measure the levels of secreted MMP-2
and MMP-9. (b) Densitometry quantification of secreted MMP-2 showed that TIMP-2
and ALA+TIMP-2 conditioned media caused a slight decrease in secreted MMP-2 in
MCF-7 cells, but a notable decrease in secreted MMP-2 in MDAMB-231 cells. Data are
representative of three independent experiments.
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3.10 TIMP-2 and ALA+TIMP-2 conditioned media caused a decrease in MMP-2
transcript levels in MDAMB-231 cells
Since decrease in invasive potential after conditioned media treatment was not due
to a decrease in MMP activity, but rather to a decrease in the levels of secreted MMP-2, it
was then examined if the conditioned media also affects transcript levels of MMP-2 and
other genes involved in the TIMP-2 pathway. To determine changes in transcript levels,
cells were incubated for 48 hours in the conditioned media and then total RNA was
extracted for semi quantitative RT-PCR. TIMP-2 and ALA+TIMP-2 conditioned media
did not change the transcript levels of RECK, TIMP-2 or β1 integrin in MCF-7 cells (Fig.
13). Similarly, TIMP-2 and ALA+TIMP-2 conditioned media did not change the
transcript levels of RECK, TIMP-2, β1 integrin, and MT-1 MMP in MDAMB-231 cells
(Fig. 14b-e). However, TIMP-2 and ALA+TIMP-2 conditioned media did significantly
decrease MMP-2 transcript levels in MDAMB-231 cells (Fig. 14f). TIMP-2 conditioned
media caused a 30% decrease in MMP-2 transcripts, whereas ALA+TIMP-2 conditioned
media caused a 43% decrease in MMP-2 transcripts in MDAMB-231 cells.
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Figure 13. TIMP-2 and ALA+TIMP-2 conditioned media did not alter transcript
levels of RECK, TIMP-2, or β1 integrin in MCF-7 cells. (a) After treating MCF-7 cells
with TIMP-2 and ALA+TIMP-2 conditioned media for 48 hours, mRNA was isolated
and transcript levels of the respective genes were examined using semi quantitative RTPCR. (b-d) Densitometry quantification of detectable transcripts is shown as relative
expression to GAPDH. There are no significant differences (p ≤ 0.05) in the transcript
levels of β1 integrin, TIMP-2, or RECK after TIMP-2 or ALA+TIMP-2 conditioned
media treatment. Data are shown as the mean and standard deviation of three independent
experiments.
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Figure 14. TIMP-2 and ALA+TIMP-2 conditioned media decreased MMP-2
transcript levels in MDAMB-231 cells. (a) After treating MDAMB-231 cells with
TIMP-2 and ALA+TIMP-2 conditioned media for 48 hours, mRNA was isolated and
gene expression was analyzed using semi quantitative RT-PCR. (b-f) Densitometry
quantification of transcript levels of the respective genes is shown as relative expression
to GAPDH. Treatment with TIMP-2 and ALA+TIMP-2 conditioned media only showed a
significant decrease in MMP-2 transcripts. Data are shown as the mean and standard
deviation of three independent experiments. Letters denote significant differences at p ≤
0.05.
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Chapter 4- Discussion
4.1 Increased expression of MT-1 MMP, MMP-2 and TIMP-2 results in increased
invasive potential
Increased levels of MT-1 MMP, MMP-2 and TIMP-2 are commonly reported in
many types of human cancers, ranging from lung to breast carcinomas (Mori et al., 1997;
Nawrocki et al., 1997; Okada et al., 1995). MT-1 MMP and MMP-2 are particularly
involved in processes leading to tumour progression as they are both potent proteolytic
enzymes whose enzymatic action allow cell invasion trough the basement membrane
(Seiki, 2003). When there is high expression of MT-1 MMP and MMP-2, TIMP-2 can
facilitate tumour progression by increasing proMMP-2 activation and by interacting with
cell surface receptors to confer a proinvasive phenotype to cancer cells (Lambert et al.,
2004; Stetler-Stevenson, 2008a). In this study, MMP-2, MT-1 MMP and TIMP-2
transcript levels, secreted MMP-2 levels, MMP activity, and invasive potential were
compared between MCF-7 and MDAMB-231 breast cancer cells. MDAMB-231 cells
expressed higher levels of MT-1 MMP, MMP-2, and TIMP-2 than MCF-7 cells (Fig. 3),
which correlated with increased secretion of MMP-2 and increased MMP activity (Fig. 4).
The significantly higher MMP activity displayed by MDAMB-231 cell is likely due to
more proMMP-2 activation mediated by the MT-1 MMP/TIMP-2 complex, since these
cells express higher levels of both these genes. Consistent with previous reports (Figueira
et al., 2009; Kohrmann et al., 2009), the higher expression of MT-1 MMP, MMP-2,
TIMP-2 and higher MMP activity displayed by MDAMB-231 cells correlates with a
higher invasive potential compared to MCF-7 cells (Fi. 5). In this study, MCF-7 and
MDAMB-231 cells were subsequently used to examine how physiological concentrations
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of TIMP-2 affect the invasive efficiency of a cancer cell line with a low invasive potential
(MCF-7) in comparison to a cancer cell line with a high invasive potential (MDAMB231).
4.2 TIMP-2 and ALA+TIMP-2 conditioned media decreased the invasive potential
of MCF-7 and MDAMB-231 cells independent of MMP inhibition
In the literature, TIMP-2 is often described as a powerful inhibitor of invasion by
inhibiting MMP activity and not allowing cells to invade through a physical barrier (Oh
et al., 2004; Stetler-Stevenson and Seo, 2005). However, studies that have claimed this
used concentrations of TIMP-2 (2.5 - 10 µg/ml) much higher than physiological
concentrations (10 – 100 ng/ml) that result in significant inhibition of MMP activity due
to the excess of TIMP-2, and decreased invasion as a result (Albini et al., 1991; Hotary et
al., 2003; Sabeh et al., 2004). Therefore, these studies did not examine how TIMP-2 can
affects invasive efficiency at physiological concentrations, or take into consideration the
MMP independent functions of TIMP-2 and how this may affect invasion.
In this study, the conditioned media used to treat the cells contained concentrations
of TIMP-2 or ALA+TIMP-2 (~42 ng/ml) that are within physiological concentrations
(10-100 ng/ml). Although both these conditioned media decreased the invasive potential
of MCF-7 and MDAMB-231 cells (Fig. 9-10), this was not accompanied by a decrease in
MMP activity, but rather an increase (Fig. 11). This indicates the decrease in invasion
after treatment with conditioned media containing physiological levels of TIMP-2 is
independent of MMP inhibition, but rather due to another effect that TIMP-2 has on cell
behaviour.
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It has been shown that TIMP-2 most efficiently activates proMMP-2 at 50ng/ml
(Sounni et al., 2010), a concentration very similar to the one in the conditioned media
used in this study (Hernandez-Barrantes et al., 2000; Worley et al., 2003). Addition of the
TIMP-2 conditioned media to the cells likely caused an increase in proMMP-2 activation
that increased MMP activity, and since there is not an excess of TIMP-2, the resulting
MMP activity remains higher than in cells treated with control media. Furthermore,
ALA+TIMP-2 conditioned media treatment resulted in the highest MMP activity in both
cell lines (Fig. 11), likely due to the non-functional N-terminal domain of this protein not
being able to inhibit MMPs. While treatment with TIMP-2 conditioned media resulted in
proMMP-2 activation, at the same time any other unbound TIMP-2 that is not
participating in the activation event then goes on to inhibit active MMP-2, thereby
decreasing MMP activity (Fig. 15a). This is in contrast to ALA+TIMP-2 conditioned
media treatment where this mutant protein can still activate proMMP-2, although not as
efficiently, but cannot inhibit the active MMP-2 or other active MMPs, therefore
resulting in higher MMP activity (Fig. 15b).
Additionally, TIMP-2 and ALA+TIMP-2 conditioned media treatment did not
cause a change in RECK transcript levels in MCF-7 (Fig. 13b) or MDAMB-231 (Fig.
14b) cells. This is consistent with the increase in MMP activity seen, as an increase in
RECK would have been accompanied by a decrease in MMP activity (Rhee and
Coussens, 2002). Although it has been reported that TIMP-2 can induce RECK
expression through α3β1 integrins, this was shown in endothelial cells by treating them
with TIMP-2 or ALA+TIMP-2 at a concentration of 2.5 µg/ml (Oh et al., 2004), 50 times
higher than the concentration used in this study.
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Figure 15. Free TIMP-2 binds the cell surface with its C-terminal domain to
influence invasive potential. (a) During TIMP-2 conditioned media treatment, the
increased levels of TIMP-2 result in increased proMMP-2 activation, while at the same
time there is inhibition of MMP activity by TIMP-2 binding the already active MMPs.
MMP inhibition by TIMP-2 results in less free TIMP-2 being available to bind the cell
surface with the C-terminal domain and influence cell behaviour. (b) During
ALA+TIMP-2 conditioned media treatment, there is less proMMP-2 activation than
during TIMP-2 conditioned media treatment, but no MMP inhibition by ALA+TIMP-2
resulting in high MMP activity. Since ALA+TIMP-2 cannot be bound and sequestered by
active MMPs, there is more free ALA+TIMP-2 available to bind the cell surface with the
C-terminal domain and signal inside the cell. The cell surface receptor that TIMP-2 is
binding may be MT-1 MMP or other unknown (??) cell surface proteins.
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4.3 The decrease in invasion of MCF-7 and MDAMB-231 cells is mediated by the Cterminal domain of TIMP-2
Since the decrease in invasion after conditioned media treatment was independent
of MMP inhibition, it was then examined how TIMP-2 affects gene expression and levels
of secreted MMP-2. Treating MDAMB-231 cells with TIMP-2 and ALA+TIMP-2
conditioned media caused a decrease in MMP-2 transcript levels (Fig. 14f) with a
concordant decrease in the levels of secreted MMP-2 protein (Fig. 12), which correlate
with the decrease in invasion (Fig. 10). This decrease in invasive efficiency, MMP-2
transcript levels, and MMP-2 secretion was of a larger magnitude after treatment with
ALA+TIMP-2 conditioned media compared to both TIMP-2 conditioned media and
control media treatments. This suggests that the C-terminal domain of free TIMP-2
mediates the effects seen in this study.
Reports that have shown MMP independent effects of TIMP-2 have noted the
importance of free TIMP-2, as TIMP-2 bound to an MMP or the TIMP-2/proMMP-2
complex is not capable of binding the cell surface and signaling inside the cell (Chesler et
al., 1995; Hayakawa et al., 1994; Stetler-Stevenson, 2008a). As mentioned previously,
during TIMP-2 conditioned media treatment TIMP-2 bound active MMPs decreasing
their activity thereby being sequestered and not being available to bind the cell surface
with the C-terminal domain (Fig. 15a). In contrast, during ALA+TIMP-2 treatment there
is more free ALA+TIMP-2 available to bind the cell surface since ALA+TIMP-2 cannot
bind MMPs and be sequestered (Fig. 15b). Therefore, in comparison to TIMP-2 treatment,
ALA+TIMP-2 treatment resulted in a more significant effect on invasion and MMP-2
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levels due to there being more ALA+TIMP-2 available to bind the cell surface with the
C-terminal and signal inside the cell.
Interestingly, results from our laboratory into the in vivo functions of TIMPs using
Xenopus laevis embryos as a model organism, demonstrated that altered expression of
different TIMP-2 constructs in developing embryos resulted in decreased MMP-2
transcript levels during development (Nieuwesteeg et al., 2012). Specifically,
microinjection of a C-terminal TIMP-2 construct, which is functionally similar to
ALA+TIMP-2, resulted in a significant decrease in MMP-2 transcript levels, but no
change in RECK or β1 integrin transcripts, trends very similar to the ones seen in this
study.
Although the effects elicited by the conditioned media seem to be mediated by the
C-terminal domain of TIMP-2 signaling inside the cell, the cell surface receptor
responsible for mediating these effects is unclear. Previous studies have shown that MT-1
MMP and α3β1 integrins are cell surface receptors of TIMP-2, but in this study it cannot
be said if either play a role in the effects seen. There are only two reports from the same
research group showing that at concentrations between 10-100 ng/ml, TIMP-2 and
ALA+TIMP-2 interact with MT-1 MMP to induce an ERK signaling cascade that results
in increased migration of breast cancer cells (D'Alessio et al., 2008; Sounni et al., 2010).
It would be reasonable to hypothesize that this signaling event would also result in
increased invasion of cells expressing MT-1 MMP. However, in this study both
MDAMB-231 and MCF-7 cells showed a decrease in invasion after conditioned media
treatments, despite the fact that MDAMB-231 cells express MT-1 MMP, whereas MCF-7
cells are deficient in MT-1 MMP (Fig. 3). It is note worthy that the cells used in those
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two reports, that being MCF-7 cells overexpressing MT-1 MMP or HT1080 cells, express
MT-1 MMP at much higher levels than MDAMB-231 cells (D'Alessio et al., 2008),
which perhaps are required to cause an increase in migration as a result of interacting
with TIMP-2.
Furthermore, although TIMP-2 can use MT-1 MMP as a cell surface receptor, it is
unlikely that MT-1 MMP on its own has the capacity to directly transmit a signal to the
inside of the cell. MT-1 MMP has a cytoplasmic domain that has been shown to be
necessary to induce TIMP-2 mediated ERK activation (D'Alessio et al., 2008), but this
cytoplasmic domain is very short and contains no unusual sequences that may be able to
directly transmit the signal to the inside of the cell (Sounni et al., 2010). Instead, it has
been proposed that MT-1 MMP serves an adaptor protein at the cell surface, which
complexes with other cell surface proteins, such as the low density lipoprotein-related
receptor protein-1 (LRP1), to transmit the signal (Strongin, 2010). However, cell surface
proteins that complex with MT- 1 MMP have not been reliably identified (Uekita et al.,
2001), and this is crucial to understanding how TIMP-2 interacts with the cell surface to
influence cell behaviour.
4.4 Overexpression of TIMP-2 and ALA+TIMP-2 constructs in MCF-7 cells
resulted in functional conditioned media
ALA+TIMP-2 is a TIMP-2 mutant protein that is especially useful in delineating
the relative contributions of the N- and C- terminal domain to the functions of TIMP-2.
Although purified human TIMP-2 is commercially available from a variety of companies,
ALA+TIMP-2 is not. Previous studies that have used ALA+TIMP-2 to study TIMP-2
function have made this protein using E. coli inclusion bodies (Wingfield et al., 1999), or
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using media from CHO transfected cells that was then dialyzed and subjected to
chromatography (Sounni et al., 2010).
Although in this study ALA+TIMP-2 treatment was in the form of conditioned
media that do contain other proteins secreted by the cells, these conditioned media do
appear to be functional as demonstrated by the different assays done in this study.
Importantly, the effect elicited by the conditioned media appear to be due to the elevated
levels of TIMP-2/ALA+TIMP-2 protein as the control media had no such effects. This
method of creating ALA+TIMP-2 conditioned media should continue to prove very
useful in our continuing studies as to how TIMP-2 affects invasive potential in vitro.
4.5 Conclusion
TIMP-2 is a multifunctional protein whose biological function is highly contextual
depending on the relative levels of other proteins with which interacts, like MT-1 MMP
or α3β1 integrins. In this study it was examined how physiological concentrations of
TIMP-2 modulate the invasive potential of breast cancer cells. It was found that
physiological levels of both TIMP-2 and a TIMP-2 mutant protein, ALA+TIMP-2,
decrease the invasive potential of MCF-7 and MDAMB-231 breast cancer cells. This
effect was independent of MMP inhibition, as both TIMP-2 and ALA+TIMP-2 caused an
increase in MMP activity. Instead, a decrease in MMP-2 transcripts and secreted MMP-2
protein was observed after conditioned media treatment. It appears that the C-terminal
domain of free TIMP-2 mediates the effect seen, as in most assays done the effect
ALA+TIMP-2 conditioned media had was more significant that TIMP-2 conditioned
media. However, this study did not examine the specific cell surface receptors that TIMP-
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2 binds at the cell surface to mediate this effect and this will be the subject of further
research.
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